These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 9283682)
21. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Domenicali M; Ros J; Fernández-Varo G; Cejudo-Martín P; Crespo M; Morales-Ruiz M; Briones AM; Campistol JM; Arroyo V; Vila E; Rodés J; Jiménez W Gut; 2005 Apr; 54(4):522-7. PubMed ID: 15753538 [TBL] [Abstract][Full Text] [Related]
22. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Pratt PF; Hillard CJ; Edgemond WS; Campbell WB Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889 [TBL] [Abstract][Full Text] [Related]
23. Differential actions of anandamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery. Zygmunt PM; Sørgård M; Petersson J; Johansson R; Högestätt ED Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):535-42. PubMed ID: 10832608 [TBL] [Abstract][Full Text] [Related]
24. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. Fulton D; Quilley J J Pharmacol Exp Ther; 1998 Sep; 286(3):1146-51. PubMed ID: 9732371 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. Lay L; Angus JA; Wright CE Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647 [TBL] [Abstract][Full Text] [Related]
27. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro. Wheal AJ; Bennett T; Randall MD; Gardiner SM Br J Pharmacol; 2007 Mar; 150(5):662-71. PubMed ID: 17245361 [TBL] [Abstract][Full Text] [Related]
28. Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat. Stanford SJ; Gitlin JM; Mitchell JA Br J Pharmacol; 2001 Jul; 133(6):825-32. PubMed ID: 11454655 [TBL] [Abstract][Full Text] [Related]
29. Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery. Zygmunt PM; Edwards G; Weston AH; Larsson B; Högestätt ED Br J Pharmacol; 1997 May; 121(1):141-9. PubMed ID: 9146898 [TBL] [Abstract][Full Text] [Related]
30. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat. Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160 [TBL] [Abstract][Full Text] [Related]
31. Cannabinoid activation of recombinant and endogenous vanilloid receptors. Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565 [TBL] [Abstract][Full Text] [Related]
32. Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. Harris D; McCulloch AI; Kendall DA; Randall MD J Physiol; 2002 Mar; 539(Pt 3):893-902. PubMed ID: 11897858 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments. Yousif MH; Oriowo MA Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656 [TBL] [Abstract][Full Text] [Related]
35. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF. Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786 [TBL] [Abstract][Full Text] [Related]